title: Recombinant antibodies in cancer therapy.
abstract: The application of recombinant immunotoxin and radioimmunoconjugate in Cancer therapy has revived the "magic bullet" concept predicted a century ago. Many of the recombinant antibodies have received FDA approval for various indication of cancer in recent years and numerous others are in clinical trials.
authors.affiliation: Department of Chemistry, Aligarh Muslim University, Aligarh-202 002, India.
authors.forename: M S
authors.initials: MS
authors.lastname: Nayeem
authors.forename: Rizwan H
authors.initials: RH
authors.lastname: Khan
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D016499:Radioimmunotherapy; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D011994:Recombinant Proteins